Document:

EXHIBIT 10.44

                          WALL STREET CONSULTANTS, INC.
                                32 E. 57th STREET
                              NEW YORK, N.Y. 10022

                        INVESTMENT BANKING (212) 888-4848
                         FOUNDED 1959 FAX (212) 888-4903

                               September 30, 2004

Mr. Richard Gabriel President & CEO DNAPrint genomics, Inc. 900 Cocoanut Avenue
Sarasota, FL 34236

Dear Mr. Gabriel:

This will confirm our understanding that The Wall Street Group, Inc. ("WSG") has
been retained as financial public relations counsel to DNAPrint genomics, Inc.
("DNAPrint"), beginning September 30, 2004 and continuing until cancelled as
hereinafter provided. As consideration for the services provided by WSG to
DNAPrint, as defined more specifically on Exhibit "A" attached, WSG will receive
a cash fee of $7,500 per month, payable in advance on the first day of each
month, plus reimbursement of reasonable and customary out-of-pocket expenses,
payable on receipt of an itemized statement detailing the incurred expenses. As
further consideration, DNAPrint grants WSG's affiliate, Wall Street
Consultant's, Inc. ("WSC") a five-year stock option, with piggyback registration
rights as more fully set forth below, on as many shares as could be purchased on
the open market for $100,000 at the closing bid price on September 24, 2004,
which option shall be evidenced by an option agreement in the form attached
hereto as Exhibit B. This contract may be cancelled by either party on ninety
(90) days written notice.

At the conclusion of 12 months, should this contract not be canceled by either
party on 90 days prior written notice, or modified, by mutual agreement, the
same terms will pertain to the next 12 month period, except that WSC will be
granted an additional five-year option on as many shares as could be bought for
$100,000 using as the exercise price, the closing bid price (or last sale price
if the common stock shall be listed on a national securities exchange) of the
common stock on the anniversary of the date of this Agreement. Each year
thereafter, this additional option grant and formula will be maintained, until
this agreement shall be canceled or modified, with each such option to be on the
terms and conditions of Exhibit A attached hereto.

DNAPrint agrees, with respect to all options granted under this contract that
for so long as such options remain exercisable and for a period of two years
thereafter, whenever DNAPrint proposes to file with the Securities and Exchange
Commission a registration statement (other than as to securities issued pursuant
to an employee benefit plan or as to a merger, acquisition or similar
transaction subject to Rule 145 promulgated under the Securities Act of 1933, as
amended), DNAPrint shall, at least 30 days prior to such filing, give written
notice of the proposed filing to WSC (or its successor or assigns, as the case
may be) setting forth the facts with respect to such proposed filing, and offer
to include in any such filing all of the shares subject to such options,
provided that DNAPrint receives a request at least 10 days prior to the proposed
filing date. All fees, disbursements and out-of-pocket expenses in connection
with the filing of any registration statement and in complying with applicable
securities and blue sky laws shall be borne by DNAPrint, all as more fully set
forth in the option agreement.

_____(DK) _____( )

This agreement can be canceled by either party on ninety (90) days written
notice. Should this agreement be canceled earlier than one year from the date
hereof as reflected below, WSC will return to DNAPrint a prorated portion of the
five-year stock option, which portion shall be based on the number of days
remaining in the twelve month retainer period. For this purpose (and all other
purposes of this agreement), the ninety (90) day period following notice of
termination shall be considered part of the retainer period.

It is understood that during the 90 day period following notice of termination,
DNAPrint will continue to honor its fee arrangement to WSG, including
reimbursement of reasonable expenses, and that WSG will continue to work on
behalf of DNAPrint.

In addition to introductions to brokers, analysts, money managers, funds and
institutions, WSG, will introduce DNAPrint to financing and investment banking
sources that can potentially assist in raising capital. If WSG is successful in
raising capital for DNAPrint through sources which have not previously been
introduced to DNAPrint or any of its officers, directors, employees or
consultants, it shall receive a 3.0% success fee of any additional funds raised.

Any disputes arising under or in connection with the interpretation of this
Agreement or the rights and obligations of the parties hereto shall be resolved
by arbitration in the City of New York under the rules of the American
Arbitration Association then obtaining. The decision of the arbitrator(s) shall
be final and binding, and judgment may be entered thereon in the Supreme Court
of the State of New York or in the United States District Court for the Southern
District of New York or any court having jurisdiction. The costs and expenses,
including counsel fees, shall be borne by each of the parties or as the
arbitrator(s) may determine at the request of any party.

As financial public relations counsel WSG must rely upon the accuracy and

<PAGE>

completeness of the information supplied by DNAPrint and its officers and
directors. DNAPrint assumes full responsibility for the accuracy and
completeness of such information. DNAPrint agrees to indemnify WSG and pay WSG's
reasonable costs and expenses (including, without limitation, attorneys' fees
and costs) in any suit or proceeding arising out of any materially inaccurate
information provided by DNAPrint or any of its officers, directors, agents or
employees to WSG. Additionally, WSG agrees to issue no press releases on behalf
of DNAPrint which have not been cleared or reviewed by Mr. Richard Gabriel or
any other corporate officer he may designate.

If this agreement meets with your approval, please sign one copy and return it
to me, along with a check representing the first month's fee and the completed
Stock Option Agreement while retaining the other copy for your files.

_____(DK) _____( )

                                       2
<PAGE>

Very truly yours,

Donald Kirsch President

DK/jg

AGREED TO:

DNAPrint genomics, Inc.

By:
Richard Gabriel
President & CEO

Dated:

_____(DK) _____( )

                                       3
<PAGE>

                                    Exhibit A

Utilizing only public information, WSG will introduce DNAPrint to a variety of
professional investor categories, including buy and sell side securities
analysts, money managers, high net worth brokers, investment letter news writers
and print, broadcast and internet journalists. WSG will also prepare and
disseminate press releases to news media and shareholders and assist the company
in the writing and editing of its shareholder messages. The effort will be
conducted in the key money markets of the United States and the objective is to
assist the company in creating a constituency which fully understands the
history of the company, its technology, its ambitions and its potential with
enough public information for these audiences to make their own decisions as to
whether or not the company merits continued attention.

_____(DK) _____( )

                                       4
<PAGE>

EXHIBIT B

                             DNAPrint genomics, Inc.

                             STOCK OPTION AGREEMENT

Option granted as of September 27, 2004 by DNAPrint genomics, Inc. (the
"Corporation") to Wall Street Consultants, Inc. (which together with its assigns
is sometimes hereinafter referred to as the "Grantee"):

1. The Option. In further consideration of the services to be provided to the
Corporation by the Grantee pursuant to that certain retainer agreement between
the Corporation and The Wall Street Group, Inc. dated September 27, 2004 (the
"Retainer Agreement"), the Corporation grants to the Grantee, effective on the
Date of Grant, a stock option (the "Option") to purchase, on the terms and
conditions herein set forth, up to the number of shares (the "Shares") of the
Corporation's fully paid, nonassessable shares of common stock, ("Common
Stock"), at the purchase price for the Shares set forth in Section 2 below, such
that the aggregate purchase price shall equal $100,000, but not less than 50,000
shares for the first year; provided, however, that in no event shall the
Corporation be required to sell a fractional Share, and the number of Shares
purchasable hereunder shall be limited accordingly.

2. The Purchase Price. The purchase price of the Shares shall be $
______________ per share (the "Option Price"), which price is the fair market
value of the Shares as of the Date of the Grant, as such Option Price shall be
adjusted from time to time pursuant to paragraph 10.

3. Exercise of Option.

(a) The Option is exercisable over a period ending five years from the Date of
Grant (the "Option Period"). The Option may be exercised from time to time
during the Option Period as to the total number of Shares subject to this Option
as determined under Section 1, or any lesser amount thereof, and the Option
shall continue as to any unexercised Shares.

(b) In the event the Grantee elects to exercise all or any portion of the
Option, the Grantee shall deliver to the Corporation written notice (the
"Notice") of such election, which Notice shall specify the number of Shares in
respect of which the Option is to be exercised, along with payment of the Option
Price of the Shares in respect of which the Option is exercised. The Option
Price shall be paid in full in United States dollars at the time of exercise;
provided, however, that if any fees are owed or expenses un-reimbursed pursuant
to the Retainer Agreement, then the exercise price may be paid by the Grantee
agreeing to credit the corporation therefore. If the Option is exercised in
accordance with the provisions of this Agreement, the Corporation shall deliver
as soon as practicable to the Grantee a certificate or certificates representing
the number of Shares in respect of which the Option is being exercised, which
Shares shall be registered in the holder's name.

4. Sale of Shares. The Grantee shall not be entitled to sell, transfer, or
distribute the Shares except pursuant to (i) an effective registration statement
under the Securities Act of 1933, as amended (the "Act"), or (ii) if there be no
registration statement in effect, pursuant to an exemption from registration
under the Act. Prior to offering or selling the Shares upon claim of exemption,
the holder shall obtain a written opinion from counsel reasonably satisfactory
to the Corporation to the effect that such exemption is available or shall
deliver a "no-action" letter from the Securities and Exchange Commission with
respect to the proposed sale, transfer or distribution of the Shares.

_____(DK) _____( )

                                       5
<PAGE>

5. Registration Rights. The Corporation agrees that, for so long as the Option
remains exercisable and for a period of two years thereafter, whenever the
Corporation proposes to file with the Securities and Exchange Commission a
registration statement (other than as to securities issued pursuant to an
employee benefit plan or as to a merger, acquisition or similar transaction
subject to Rule 145 promulgated under the Securities Act), the Corporation
shall, at least 30 days prior to such filing, give written notice of such
proposed filing to the Grantee setting forth the facts with respect to such
proposed filing, and shall offer to include in any such filing the Shares
subject to the Option provided that the Corporation receives a request therefore
at least 10 days prior to the proposed filing date. All fees, disbursements and
out-of-pocket expenses in connection with the filing of any registration
statement and in complying with applicable securities and blue sky laws shall be
borne by the Corporation.

The Corporation will indemnify and hold harmless the Grantee and each person who
controls the Grantee within the meaning of Section 15 of the Act or Section 20
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), from
and against any and all losses, claims, damages, expenses and liabilities, joint
or several (including any investigation, legal and other expenses incurred in
connection with, and any amount paid in any settlement effected with the
Corporation's consent (not to be unreasonably withheld) of, any action, suit or
proceeding or any claim asserted), to which they, or any of them, may become
subject under the Act, the Exchange Act or other federal or state law or
regulation, at common law or otherwise, insofar as such losses, claims, damages
or liabilities arise out of or are based on (A) any untrue statement or alleged
untrue statement of a material fact contained in the registration statement
filed with respect to the Shares (including any related preliminary or
definitive prospectus, or any amendment or supplement to such registration
statement or prospectus), (B) any omission or alleged omission to state in such
document a material fact required to be stated in it or necessary to make the
statements in it not misleading, or (C) any violation by the Corporation of the
Act, the Exchange Act, any blue sky laws or any rule or regulation thereunder in
connection with such registration; provided however, that the Corporation will
not be liable to the extent that such loss, claim, damage, expense or liability
arises from and is based solely on a material untrue statement or omission or
alleged material untrue statement or omission made in such registration
statement and in conformity with information furnished in writing to the
Corporation by the Grantee expressly for use in such registration statement.
With respect to the matter referred to in the proviso of the foregoing sentence,
the Grantee will indemnify and hold harmless the Corporation from and against
any and all losses, claims, damages, expenses and liabilities, joint or several,
to which it may become subject under the Act, the Exchange Act or other federal
or state statutory law or regulation, at common law or otherwise to the same
extent provided in the immediately preceding sentence.

Promptly after receipt by an indemnified party of notice of the commencement of
any action involving matters referred to in the foregoing paragraph, such
indemnified party will, if a claim in respect thereof is to be made against any
indemnifying party, thereof and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof at its own expense with counsel reasonably satisfactory to the
indemnified party or parties, and in such case, if the indemnified party desires
to retain its own counsel, the expense of such counsel shall be borne by the
indemnified party.

_____(DK) _____( )

                                       6
<PAGE>

6. Termination of Retainer Agreement. In the event the engagement of the Wall
Street Group, Inc. under the Retainer Agreement ceases by reason of the
termination of the Retainer Agreement by either party on ninety (90) days notice
pursuant to the provisions thereof, the maximum number of Shares exercisable
hereunder shall be multiplied by a fraction, the numerator of which shall be the
number of days which shall have expired from the Date of Grant to the earlier of
the next subsequent anniversary date of the Retainer Agreement or ninety (90)
days after receipt by the Wall Street Group, Inc. of the notice of termination
sent pursuant thereto, and the denominator of which shall be 365, and such
product shall thereupon be the maximum number of Shares purchasable hereunder;
provided, however, that in no event shall the Corporation be required to sell a
fractional Share, and the number of Shares purchasable hereunder shall be
limited accordingly.

7. Successors and Assigns. This agreement shall be binding upon and shall inure
to the benefit of the parties' respective successors and assigns.

8. Expiration of Option. This Option is not exercisable after the expiration of
five years from the Date of Grant.

9. Rights.

(a) The granting of this Option shall not confer upon the Grantee any right to
continue to be retained by the Corporation or any of its subsidiaries, subject,
however, to the terms of the Retainer Agreement between the Grantee and the
Corporation.

(b) The Grantee shall not, by reason of the granting to it of the Option, have
or thereby acquire any rights of a stockholder of the Corporation with respect
to any Shares unless and until it has tendered full payment of the Option Price
for such Shares.

10. Adjustment of Number of Shares and Option Price. In the event that a
dividend shall be declared upon the Shares payable in shares of Common Stock,
the number of Shares then subject to the Option and the Option Price shall be
adjusted by adding to each of such Shares the number of shares of Common Stock
which would be distributable thereon if such Share had been outstanding on the
date fixed for determining the stockholders entitled to receive such stock
dividend and reducing the Option Price proportionally. In the event that the
outstanding Shares shall be changed into or exchanged for a different number or
kind of shares of stock or other securities of the Corporation or of another
corporation, whether through reorganization, recapitalization, stock split-up,
combination of shares, merger or consolidation, then there shall be substituted
for each Share subject to the Option the number and kind of shares of stock or
other securities into which each outstanding share of Common Stock shall be so
changed or for which each such share shall be exchanged; provided, however, that
in the event that such change or exchange results from a merger or
consolidation, and in the judgment of the Board of Directors of the Corporation
such substitution cannot be effected or would be inappropriate, or if the
Corporation shall sell all or substantially all of its assets, the Corporation
shall use reasonable efforts to effect some other adjustment of the Option which
the Board of Directors, in its sole discretion, shall deem equitable. In the
event that there shall be any change, other than as specified above in this
Paragraph 10, in the number or kind of outstanding Shares or of any stock or
other securities into which such Shares shall have been changed or for which
they shall have been exchanged, then, if the Board of Directors shall determine
that such change equitably requires an adjustment in the number or kind of
Shares then subject to the Option, such adjustment shall be made by the Board of
Directors and shall be effective and binding for all purposes of this Option. In
the case of any such substitution or adjustment as provided for in this
paragraph, the Option Price will be the option price for all shares of stock or
other securities which shall have been substituted for each Share or to which
such Share shall have been adjusted pursuant to this paragraph 10. No adjustment
or substitution provided for in this paragraph 10 shall require the Corporation
to sell a fractional Share, and the total substitution or adjustment shall be
limited accordingly.

_____(DK) _____( )

                                       7
<PAGE>

11. Reserve of Shares. The Corporation will reserve and set about and have at
all times, free from preemptive rights, a number of shares or authorized but
unissued Common Stock deliverable upon exercise of the Option, and it will have
at all times any other rights or privileges provided for therein sufficient to
enable it at any time to fulfill all of its obligations in this Agreement.

12. Governing Law. This Agreement shall be governed by, and construed and
enforced in accordance with, the laws of the State of New York.

If the foregoing is in accordance with the Grantee's understanding and approved
by it, it may so confirm by signing and returning the duplicate of this
Agreement delivered for that purpose.

DNAPrint genomics, Inc.

Dated:__________ By:_________________________

The foregoing is in accordance with the undersigned's understanding and is
hereby confirmed and agreed to as of the Date of Grant.

                          WALL STREET CONSULTANTS, INC.

Dated:__________ By:_______________________

                                       8AGREEMENT

      This is an agreement (the "Agreement") made between Charleston Holdings,
LLC, a Delaware limited liability company, with offices in Charleston, South
Carolina ("Charleston"), and The Knockout Group, Inc., a Delaware corporation
with offices in Chicago, Illinois ("Knockout") on July 22, 2004 ("Effective
Date").

                                    PREAMBLE

      Charleston is the owner of certain "trade secrets," as that term is
defined in ss.39-8-20 of the South Carolina Trade Secrets Act, which trade
secrets pertain to certain information, formulae, techniques, methodologies, and
processes (the "Secret Formulae") utilized in the production of various
household and commercial cleaning products (collectively, the "Products").

      The parties wish Knockout to market, sell, advertise and distribute the
Products," and to have the protections afforded by (he patent and trademark laws
of the United States with respect to the Products, The parties wish Charleston
to be the exclusive forraulator, and to have the right, at the direction and
approval of Knockout, to contract with an approved manufacturer of the Secret
Formulae for the Products, and otherwise to have all of the protections afforded
to an exclusive licensee of such rights.

      Accordingly, the parties wish to enter into this Agreement in order to
provide for the transfer and assignment of the Secret Formulae by Charleston to
Knockout, and for the grant of exclusive manufacturing rights of the Products by
Knockout to Charleston. In consideration of the foregoing, and other valuable
consideration, the receipt and sufficiency of which is hereby acknowledged by
the parties, it is mutually agreed by and between Charleston and Knockout as
follows:

                                    AGREEMENT

      1. Sale of Secret Formulae.

Charleston hereby sells, assigns, transfers and conveys ownership to knockout
the Secret Formulae as described with more particularity in Exhibit "A" annexed
hereto and made a part hereof by reference. Such assignment shall include all
right, title and interest in the Secret Formulae, any derivatives and
improvements thereof, including, without limitation, the right to apply for and
obtain such patents, trademarks, trade names, and other identifying marks as
Knockout may choose to pursue. Charleston agrees to execute any documents
necessary or reasonably requested by Knockout to effect evidence of the
assignment. Anything contained hereinabove to the contrary notwithstanding,
Charleston makes no warranties or representations concerning the patentability
of the Secret Formulae, nor ils eligibility for trademark, trade name, or any
other form of registration.

                                       1
<PAGE>

      2. Exclusive Manufacturing Rights.

      A. Knockout hereby grants to Charleston the worldwide, exclusive right to
      formulate and/or contract with an approved manufacturer to formulate the
      Secret Formulae and any derivatives and improvements thereof, i.e. the
      ingredients and specific method of combining to form a concentrate (the
      "Ingredients"). Such Ingredients shall include all Ingredients which are
      to be incorporated into cleaning products as sold and distributed by
      Knockout. In addition to formulating and/or manufacturing the Ingredients
      for the Products pursuant to the Secret Formulae, Charleston shall be
      responsible for tilling containers with the Ingredients (fifty-five gallon
      drums, 1,000 liter tanks, etc.), and shipping the Ingredients to
      packagers/bottlers designated by Knockout.

      B. Should Charleston identify an application for the Ingredients in a
      market that o Knockout is not interested in pursuing, then Charleston
      shall have the right to market" and sell the Ingredients in the approved
      market with the express written approval, not withheld unreasonably, by
      Knockout and paying a royalty to Knockout of twenty cents (0.20) for each
      gallon of ready to use Product containing the Ingredients. Charleston may
      not use the names or any trademarks associated with Knockout's Products in
      the sales and marketing of Ingredients in the approved market.

      In such an event as set forth in this paragraph 2(B), that Knockout
      approves in writing for Charleston to formulate and/or manufacture
      Ingredients for use in cleaning products other than those which arc
      marketed, sold, advertised or distributed by Knockout ("Offproduct
      Ingredients"), then and in such event, Charleston shall pay to Knockout a
      royalty of Twenty Cents ($0.20) for each ready to use retail gallon
      containing the Offproduct Ingredients so formulated/manufactured by
      Charleston. Such payment shall be made by Charleston to Knockout within
      ten (10) days following receipt by Charleston of payment to it by the
      purchaser of such Offproduct Ingredients. Charleston shall keep accurate
      books and records of account with respect to such Offproduct Ingredient's,
      and shall furnish to Knockout complete and accurate statements of account
      for all Offproduct Ingredients sold by Charleston within fifteen (15) days
      following the end of each calendar quarter. If an audit or inspection of
      Charleston's books and records indicate that sales reported or royalties
      paid for any quarter shall have been under reported or underpaid by more
      than ten (10) percent, Charleston shall be in material breach of this
      Agreement, and in addition to other remedies available to Knockout,
      Charleston shall immediately reimburse Knockout's costs of the audit or
      inspection. Any overpayments to Knockout shall be recouped solely from
      future royalties payable to Knockout, and no reimbursement shall be
      required in connection therewith.

                                       2
<PAGE>

3. Approved Manufacturer.

      A. Charleston and Knockout presently designate Cessco, Inc. as an initial
      contract manufacturer of the Ingredients ("Approved Manufacturer").
      Charleston shall establish and maintain as well as supply Knockout with
      standard operating procedures to be approved in advance by Knockout
      relating to the manufacturing of the Ingredients and blending process that
      will be used by Cessco and any subsequent Approved Manufacturers of the
      Ingredients and bottlers. If Charleston fails to provide the Ingredients
      according to Knockout's business needs, Knockout and Charleston will
      cooperate fully and promptly in good faith to select other Approved
      Manufacturers for the Ingredients.

      B. If Charleston elects not to manufacture or fails to deliver the
      prcordered concentrate in the required specifications within 60 days of
      the receipt of a purchase" order and/or requirements of a purchase order,
      Charleston agrees that Knockout shall have the option, to have a third
      party Approved Manufacturer to buy bulk Ingredients to mix, bottle and
      package the Products. Should Knockout select this option due to its
      business needs, the following alternative royalty structure shall be in
      effect: Knockout will pay to Charleston SO.20 per gallon of ready to use
      Product produced, 60 days from production completion paid by the first of
      each month.

      C. Quality Assurance. Charleston shall be responsible for maintaining a
      quality control program for the formulation and manufacture of the
      Ingredients consistent with industry standards and Knockouts manufacturing
      specifications and requirements, and Knockout's packager/bottler shall be
      responsible for mixing, labeling and packaging the Ingredients; however,
      Knockout shall retain the right to reasonably set or modify the quality
      standards and to have a third party work with Charleston and/or Approved
      Manufacturer(s) to assure overall quality of Ingredients and/or Products.

4. Payment.

      A. All purchase orders for Ingredients shall be submitted directly to
      Charleston for an Approved Manufacturer being managed by Charleston.
      Knockout shall pay to Charleston the sum of Twenty-four Dollars ($24.00)
      for each gallon of Ingredients supplied by Charleston (or its Approved
      Manufacturer) to Knockout (or to Knockout's packagers/bottlers). The price
      of Ingredients shall not increase during the term of this Agreement.
      Charleston has agreed to defer the payment of a portion of the purchase
      price for one (I) year, and a portion of the purchase price for one
      hundred eighty (180) days. Knockout has agreed to pay a portion of the
      purchase price at the time it places an order for Ingredients. The
      calculation and timing of the amounts payable shall be as follows: The
      portion of the purchase price that shall be deferred for one (1) year
      shall be the equivalent of twenty percent (20%) of the gross purchase
      price of the Ingredients that are being ordered. Based upon a price of

                                       3
<PAGE>

      Twenty-four Dollars ($24.00) per gallon, the sum of Four and 80/100
      Dollars ($4.80) shall be deferred for one (1) year from the date of the
      receipt of a purchase order by Charleston. That portion of the purchase
      price that shall be paid by Knockout to Charleston upon the submission of
      an order for Ingredients shall be seventy percent (70%) of the gross
      purchase price less the amount deferred for one (1) year. Based upon a
      purchase price of Twenty-four Dollars ($24.00) per gallon, that equates to
      Thirteen and 44/100 Dollars ($13.44) ($24.00 - $4.80 = $19.20 X 0.70 =
      $13.44). The balance of the purchase price, or Five and 76/100 Dollars
      ($5.76), shall be paid by Knockout within one hundred eighty (ISO) days of
      the receipt by Charleston of a purchase order. All payments required
      hereunder shall be in good collected funds. Charleston shall refund
      amounts paid for any delivered Ingredients that do not meet the quality
      standard as required by Knockout.

      B. Charleston and Knockout shall endeavor to improve the Secret Formulae
      and reduce the costs associated with the manufacturing of such
      Ingredients, while maintaining the quality control standard set by
      Knockout, while such cost savings shall be mutually shared between the
      parties. ' '

5. Term and Termination;

      The term of this Agreement shall commence as of the date hereof, and shall
      continue until terminated in accordance with the provisions set forth
      hereinafter. It is the intention of the parties that the Agreement shall
      remain in full force and effect so long as neither of them is in breach
      and so long as Knockout continues to include the Ingredients in its
      cleaning products.

      (a)   Termination by Knockout.

            Knockout may terminate this Agreement for the following reasons:

                  (i)   If Charleston defaults in its obligations to procure and
                        maintain insurance as required herein;

                  (ii)  If Charleston shall become insolvent (as determined by
                        judicial adjudication), shall make an assignment for the
                        benefit of creditors, or shall have a petition in
                        bankruptcy filed for or against it, and such termination
                        shall be "effective immediately upon Knockout giving
                        written notice io Charleston;

                  (iii) If Charleston shall be convicted of a felony related to
                        the manufacture, use, or sale of Ingredients or
                        Products; or

                  (iv)  If Charleston defaults in the performance of any of its
                        other obligations under this Agreement and the default
                        has not been cured within sixty (60) days of receivin;
                        written notice from Knockout of such default.

                                       4
<PAGE>

      (b)   Termination by Charleston.

            Charleston may terminate this Agreement for the following reasons:

                  (i)   If Knockout defaults in its obligations to procure and
                        maintain insurance as required herein;

                  (ii)  If Knockout shall become insolvent (as determined by
                        judicial adjudication), shall make an assignment for the
                        benefit of creditors, or shall have a petition in
                        bankruptcy filed for. or against it, and such
                        termination shall be effective immediately upon
                        Charleston giving written notice to Knockout;

                  (iii) If Knockout shall be convicted of a felony related to
                        the manufacture, use, or sale of Ingredients or
                        Products; (iv) If Knockout shall cease manufacturing,
                        marketing, selling, or distributing Products;

                  (v)   If Knockout defaults in the performance of any of its
                        other obligations under this Agreement and the default
                        has not been cured within sixty (60) days of receiving
                        written notice from Charleston of such default.

Charleston's Covenants, Warranties, and Indemnifications.
      (a) Charleston covenants with Knockout as follows:

      Charleston shall provide Ingredients and all specifications for and review
      all tests for each lot of Ingredients purchased by Knockout and
      formulated/manufactured by an Approved Manufacturer, and Charleston shall
      guarantee the quality of all products provided to Knockout.

      (b) Charleston shall comply with all applicable laws and regulations in
      connection with its formulation, manufacturing, or packaging of the
      Ingredients, and Charleston shall be solely responsible for any violation
      of such laws and regulations by Charleston, or its affiliates or agents.
      Charleston shall defend and hold Knockout harmless in the event of any
      legal action of any nature occasioned by the violation by Charleston of
      such laws or regulations.

      (c) Charleston warrants and represents to Knockout the following, which
      shall remain true and correct for the duration of this Agreement:

                                       5
<PAGE>

                  (i)   Charleston is a duly organized corporation, validly
                        existing and in good standing under the laws of
                        Delaware, and has taken all corporate action necessary
                        to enter into and perform this Agreement;

                  (ii)  The Secret Formulae are original, Charleston is the sole
                        owner thereof, Charleston has sole right and full power
                        to enter into this Agreement, and Charleston will not
                        enter into any contract, agreement, or understanding
                        with respect thereto that conflicts with the rights
                        granted to Knockout hereunder; and

                  (iii) The Secret Formulae do not infringe upon any proprietary
                        right at common law, or any statutory rights such as
                        copyright or patent rights, or any other right of any
                        third party in contravention of law;

                  (jvj  Charleston has fully and completely disclosed the Secret
                        Formulae including all ingredients, methods of combining
                        and manufacturing the same, and has fully and completely
                        disclosed the best known formulation of Ingredients (o
                        Knockout. 'to(1)

            (d) Charleston represents, warrants and covenants that should any of
the aforementioned representations or warranties be breached by Charleston, it
agrees to take such actions necessary to cause Knockout to have the continued,
uninterrupted right to sell, market and advertise the Products using the Secret
Formulae in accordance with the terms of this Agreement and for the duration
hereof provided that this Agreement is not othc! wise terminated due to the
breach thereof by Knockout.

            (e) During such lime as this Agreement shall be in effect,
Charleston shall, at its sole cost and expense, procure and maintain commercial
general liability insurance in an amount of not less than One Million Dollars
($1,000,000) naming Knockout as an additional insured. Such commercial general
liability insurance shall provide (A) product liability coverage and (B) broad
form contractual liability coverage for Knockout's indemnification under this
Agreement. The minimum amounts of insurance coverage required shall not be
construed to create a limit of Charleston's liability with respect to its
indemnification under this Agreement. Charleston shall furnish Knockout with
written evidence of such insurance upon request of Knockout. Charleston shall
provide Knockout with written notice at least fifteen (15) days prior to the
cancellation, non-renewal or material change in such insurance; if Charleston
does not obtain replacement insurance providing comparable coverage within such
fifteen (15) day period, Knockout shall have the right to terminate this
Agreement effective at the end of such fifteen (15) day period without notice or
any additional waiting periods. Charleston shall maintain such commercial
general liability insurance, on an occurrence basis, beyond the expiration or
termination of this Agreement

                                       6
<PAGE>

      during the period that any product, process, or service, relating to, or
      developed pursuant to, this Agreement is being commercially distributed or
      sold by Knockout, or any of its affiliates or agents.

            (f) Charleston shall indemnify, defend, and hold Knockout harmless
against any damage or judgment, including court costs and attorney's fees, which
may be sustained by or recovered against Knockout arising from Charleston's
breach or violation of the terms of this Agreement or the warranties applicable
to Charleston contained herein or any claim inconsistent with any with any
warranty or representation of Charleston contained herein. Charleston shall also
reimburse Knockout for all expenses including court costs, attorney's fees, and
amounts paid in settlement (to which settlement Charleston has consented)
sustained by Knockout in resisting any claim, demand, suit, action, or
proceeding asserted or instituted against Knockout based upon any breach or
violation of the warranties of Charleston contained herein or any claim
inconsistent with any warranty or ' representation of Charleston contained
herein. Knockout shall advise Charleston of any such claim, demand, or action
promptly after Knockout has been advised thereof, and Charleston shall have the
right (to the extent Knockout has such right) to assist and participate, at
Charleston's expense, in any defense thereof through counsel of Charleston's
choosing.

7, Knockout's Covenants, Warranties, jind Indemnifications, (a)

            Knockout covenants with Charleston as follows:

                  (i)   Knockout shall use diligent efforts to effect
                        introduction of the Products into the marketplace as
                        soon as practicable, consistent with sound and
                        reasonable business practice and judgment; thereafter,
                        until the termination of this Agreement, Knockout shall
                        endeavor to keep the Products reasonably and publicly
                        available to the end users thereof.

                  (ii)  During such time as this Agreement shall be in effect,
                        Knockout shall, at its sole cost and expense, procure
                        and maintain commercial general liability insurance in
                        an amount not less than One Million Dollars ($1,000,000)
                        and naming Charleston as an additional insured. Such
                        commercial general liability insurance shall provide (A)
                        product liability coverage and (B) broad form
                        contractual liability coverage for Charleston's
                        indemnification under this Agreement. The minimum
                        amounts of insurance coverage required shall not be
                        construed to create a limit of Knockout's liability with
                        respect to its indemnification

                                       7
<PAGE>

                        under this Agreement. Knockout shall furnish Charleston
                        with written evidence of such insurance upon request of
                        Charleston. Knockout shall provide Charleston with
                        written notice at least fifteen (15) days prior to the
                        cancellation, non-renewal or material change in such
                        insurance; if Knockout does not obtain replacement
                        insurance providing comparable coverage within such
                        fifteen (15) day period, Charleston shall have the right
                        to terminate this Agreement effective at the end of such
                        t 24 24 fifteen (15) day period without notice or any
                        additional waiting periods. Knockout shall maintain such
                        commercial general liability insurance, on an occurrence
                        basis, beyond the expiration or termination of this
                        Agreement during the period that any product, process,
                        or service, relating to. or developed pursuant to, this
                        Agreement is being commercially distributed or sold by
                        Knockout, or any of its affiliates or agents. o '

                  (lii) Knockout shall comply with all applicable laws and
                        regulations in connection with its packaging,
                        distribution, marketing, advertising, or sale of the
                        Products and Knockout shall be solely responsible for
                        any violation of such laws and regulations by Knockout,
                        or its affiliates or agents, except to the extent of not
                        properly labeling Products due to Charleston's failure
                        to provide the necessary labeling information to
                        Knockout required under Section 3. Knockout shall defend
                        and hold Charleston harmless in the event of any legal
                        action of any nature occasioned by Ihe violation by
                        Knockout of such laws or regulations.

<PAGE>

(b) Knockout represents and warrants to Charleston the following, which shall
remain true and correct for the duration of this Agreement:

                  (i)   Knockout is a duly organized corporation, validly
                        existing and in good standing under the laws of
                        Delaware, and has taken ail corporate action necessary
                        to enter into and perform this Agreement;

                  (ii)  Knockout shall be the sole owner of the Secret Formulae,
                        has full power to enter into this Agreement, and has not
                        entered, and will not enter, into or become subject to
                        any contract, agreement or understanding with respect
                        thereto which would conflict with the rights granted to
                        Charleston hereunder and

                                       8
<PAGE>

            (c)   Knockout shall indemnify and hold Charleston harmless against
                  any damage or judgment, including court costs and attorney's
                  fees, which may be sustained by or recovered against
                  Charleston arising from Knockout's breach or violation of the
                  terms of this Agreement or the covenants or warranties
                  applicable to Knockout contained herein or any claim
                  inconsistent with any warranty or representation of Knockout
                  contained herein. Knockout shall also reimburse Charleston for
                  all expenses including court costs, attorney's fees, and
                  amounts paid in settlement (to which settlement Knockout has
                  consented) sustained by Charleston in resisting any claim,
                  demand, suit, action, or proceeding asserted or instituted
                  against Charleston based upon any breach or violation of the
                  warranties of Knockout contained herein or any claim
                  inconsistent with any warranty or representation of Knockout
                  contained herein. Charleston shall advise Knockout of any such
                  claim, demand, or action promptly after Charleston has been
                  advised thereof, and Knockout shall have the right (to the
                  extent Charleston has such right) to assist and participate,
                  at Knockout's expense, in any defense thereof through counsel
                  of Knockout's choosing.

8.   MISCELLANEOUS.

8.1. Successors; Assignment. This Agreement shall be binding upon and inure io
the benefit of the parties and iheir respective heirs, executors,
administrators, legal representatives, successors, and assigns. Charleston may
not assign this Agreement without prior written consent of Knockout.

8.2 Notices. Notices given by either party must be in writing and shall be
mailed by certified or registered first class mail, return receipt requested,
overnight delivery service, or personally delivered to the addresses set forth
below, as amended in writing from time to time. All notices shall be effective
the earlier of three days from the date of mailing or upon receipt.

8.3. Integration. This Agreement superccdes any other agreements and represents
the entire agreement and understanding between-Knockout and Charleston. No
waiver, alteration, or modification of any of the provisions of this Agreement
shall be binding unless in writing and signed by a duly authorized
representative of the party against which enforcement of such waiver,
alteration, or modification is sought.

8.4. Governing Law. For purposes of any and all disputes with respect to this
Agreement, the parties consent to jurisdiction and venue in the state and
federal courts located in the Stale of Delaware.

                                       9
<PAGE>

8.5. Binding Authority. The individuals executing this Agreement further warrant
that they have the full power and authority to bind their respective entities to
the terms hereof and have been duly authorized to do so in accordance with such
entities' corporate or other organizational documents and procedures.

8.6. Captions, Sections. Captions contained herein are inserted only as a matter
of convenience and in no way define, limit, or extend the scope or intent of any
provision hereof. Use of the term "Section" shall include the entire subject
Section and all its subsections where the context requires. 8.7. Waiver. Failure
or delay on the part of either party to exercise any right, power or privilege
hereunder shall not operate as a waiver thereof. A waiver of one obligation
hereunder shall not operate as a waiver of any other obligation.

8.8 Scverabilily. If any provision of this Agreement is held to be ineffective,
unenforceable or illegal for any reason, such decision shall not affect the
validity or enforceability of any or ail of the remaining portions thereof.

Understood and agreed to by the duly authorized representatives of the parties
as evidenced by their respective signatures below. The parties have executed
this Agreement as of the dale first written above.

Charleston Holdings, LLC

By: /s/ Karl A. Heise Jr.
Title: Its President

The Knockout Group, Inc.

By: /s/ John Bellamy
Title: CEO

                                       10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]